echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Gospel of dry eye!

    Gospel of dry eye!

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Novaliq announced that the second pivotal phase 3 clinical trial of CyclASol, a topical anti-inflammatory eye drops under investigation, for the treatment of dry eye (DED) has achieved positive results


    Dry eye is one of the most common chronic diseases of the eye, affecting the quality of life of millions of people.


    Based on Novaliq's proprietary EyeSol technology platform for anhydrous drug delivery, CyclASol is an immunomodulator with local anti-inflammatory effects, containing 0.


    This randomized, double-blind, vehicle-controlled, multi-center, pivotal phase 3 clinical trial was carried out in 328 patients with dry eye who did not respond to artificial tears


    In terms of safety, the number of adverse events (AE) in the trial was low, usually mild


    Reference materials:

    [1] Novaliq Announces Positive Topline Results for Second Phase 3 Trial (Essence-2) of CyclASol® in Dry Eye Disease.


    [2] Sheppard, JD, et, al.


    (The original text has been deleted)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.